ALS Drug Wins FDA Approval Despite Questionable Data
The drug Relyvrio. (Amylyx Pharmaceuticals via AP)
The drug Relyvrio. (Amylyx Pharmaceuticals via AP)
The drug Relyvrio. (Amylyx Pharmaceuticals via AP)
Guilhem Gallart, known as Pone, lies on a bedat his home in Gaillac in the south of France on June 16, 2021. Since 2015, he suffers from amyotrophic lateral sclerosis.…